The Food and Drug Administration on Thursday authorized a second antiviral pill for COVID but said it should not be preferred over other treatments. The FDA cleared the pill, developed by Merck and ...

Molnupiravir, an antiviral COVID-19 pill created by Merck, has been linked with new mutations of the virus that have been observed worldwide, according to a new study published in the Nature science ...

WASHINGTON - U.S. health regulators on Thursday authorized Merck’s COVID-19 pill, known as molnupiravir — the second medication approved for at-home use to battle the rapidly-spreading omicron variant ...

WASHINGTON (AP) — U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant. The Food and ...

The European Union’s drug regulator on Friday advised that an experimental COVID-19 pill from Merck should be given within five days of first symptoms to treat adults who do not need oxygen support ...

WASHINGTON - Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.

Capsules of the experimental anti-Covid drug molnupiravir, for which Merck is seeking emergency use authorization in the US – Copyright AFP Peter PARKS US ...